Trial Profile
A phase IIb/III study of ABM-125 in patients with Atopic dermatitis
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 23 May 2017
Price :
$35
*
At a glance
- Drugs LNR 125.38 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 23 May 2017 New trial record